Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.08B
| $2.39M | ﹤0.01% |
30,541
+22,007
| +258% | +$1.43M |
|
3352
Navient
NAVI
$892M
| $2.38M | ﹤0.01% |
338,948
-95,532
| -22% | -$711K |
|
3353
Millicom
TIGO
$17.5B
| $2.38M | ﹤0.01% |
91,165
+24,704
| +37% | +$641K |
|
|
NXJ
3354
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $2.38M | ﹤0.01% |
179,699
-8,144
| -4% | -$107K |
|
3355
GeoPark
GPRK
$617M
| $2.38M | ﹤0.01% |
243,108
+13,399
| +6% | +$120K |
|
3356
Archrock
AROC
$5.85B
| $2.38M | ﹤0.01% |
366,093
-84,613
| -19% | -$442K |
|
|
CAF
3357
Morgan Stanley China A Share Fund
CAF
$321M
| $2.38M | ﹤0.01% |
121,827
-11,208
| -8% | -$210K |
|
3358
UroGen Pharma
URGN
$2.22B
| $2.38M | ﹤0.01% |
91,031
+87,825
| +2,739% | +$2.15M |
|
3359
Hancock Whitney
HWC
$6.22B
| $2.38M | ﹤0.01% |
112,001
+55,954
| +100% | +$1.15M |
|
3360
WBI Power Factor High Dividend ETF
WBIY
$63.8M
| $2.37M | ﹤0.01% |
126,622
-3,125
| -2% | -$55.3K |
|
|
CHCT
3361
Community Healthcare Trust
CHCT
$446M
| $2.37M | ﹤0.01% |
57,941
+3,723
| +7% | +$139K |
|
3362
ProQR Therapeutics
PRQR
$268M
| $2.37M | ﹤0.01% |
389,878
+186,396
| +92% | +$1.01M |
|
|
PRNB
3363
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.37M | ﹤0.01% |
39,631
+37,609
| +1,860% | +$2.32M |
|
3364
Invesco S&P MidCap 400 GARP ETF
GRPM
$498M
| $2.37M | ﹤0.01% |
40,846
-4,521
| -10% | -$242K |
|
3365
National Bank Holdings
NBHC
$1.91B
| $2.36M | ﹤0.01% |
87,486
+2,297
| +3% | +$58.5K |
|
3366
MKS Inc
MKSI
$19.7B
| $2.36M | ﹤0.01% |
20,857
-19,652
| -49% | -$1.96M |
|
|
OXFD
3367
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.36M | ﹤0.01% |
181,644
+36,571
| +25% | +$439K |
|
3368
Vanda Pharmaceuticals
VNDA
$309M
| $2.35M | ﹤0.01% |
205,828
-379,144
| -65% | -$4.29M |
|
|
ERH
3369
Allspring Utilities & High Income Fund
ERH
$104M
| $2.35M | ﹤0.01% |
181,947
-3,721
| -2% | -$45.8K |
|
3370
Heritage Financial
HFWA
$1.21B
| $2.35M | ﹤0.01% |
117,534
+10,591
| +10% | +$200K |
|
3371
Fidelity MSCI Utilities Index ETF
FUTY
$2.28B
| $2.34M | ﹤0.01% |
64,278
+9,853
| +18% | +$367K |
|
|
ACH
3372
Accendra Health
ACH
$224M
| $2.34M | ﹤0.01% |
307,625
-683,792
| -69% | -$5M |
|
3373
Imperial Oil
IMO
$61.1B
| $2.33M | ﹤0.01% |
145,224
-698,990
| -83% | -$10.5M |
|
|
NHS
3374
Neuberger High Yield Strategies Fund Inc
NHS
$254M
| $2.33M | ﹤0.01% |
225,235
-5,388
| -2% | -$54.1K |
|
3375
Casella Waste Systems
CWST
$5.75B
| $2.33M | ﹤0.01% |
44,642
-19,485
| -30% | -$930K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.